Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Govindarajan Shanmugam"'
Autor:
Azger Dusthackeer, Shainaba A. Saadhali, Manonanthini Thangam, Sameer Hassan, Mahizhaveni Balasubramanian, Angayarkani Balasubramanian, Geetha Ramachandran, A. K. Hemanth Kumar, Kannan Thiruvenkadam, Govindarajan Shanmugam, Christy Rosaline Nirmal, Sam Ebenezer Rajadas, Sucharitha Kannappan Mohanvel, Rajesh Mondal
Publikováno v:
Frontiers in Microbiology, Vol 11 (2020)
The World Health Organization (WHO) has developed specific guidelines for critical concentrations (CCs) of antibiotics used for tuberculosis (TB) treatment, which is universally followed for drug susceptibility testing (DST) of clinical specimens. Ho
Externí odkaz:
https://doaj.org/article/d28c93fc725547d8b3a5682cc8b39bb3
Autor:
Azger Dusthackeer, Magizhaveni Balasubramanian, Govindarajan Shanmugam, Shanmuga Priya, Christy Rosaline Nirmal, Rajadas Sam Ebenezer, Angayarkanni Balasubramanian, Rajesh Kumar Mondal, Kannan Thiruvenkadam, A. K. Hemanth Kumar, Geetha Ramachandran, Selvakumar Subbian
Publikováno v:
Frontiers in Microbiology, Vol 10 (2019)
Tuberculosis (TB) remains a leading killer among infectious diseases of humans worldwide. Delayed diagnosis is a crucial problem in global TB control programs. Bacteriological methods currently used to diagnose TB in endemic countries take up to 8 we
Externí odkaz:
https://doaj.org/article/b926df4005764f7a88291b9f76891c23
Autor:
Sucharitha Kannappan Mohanvel, A K Hemanth Kumar, Sam Ebenezer Rajadas, Azger Dusthackeer, Angayarkani Balasubramanian, Manonanthini Thangam, Sameer Hassan, Govindarajan Shanmugam, Mahizhaveni Balasubramanian, Christy Rosaline Nirmal, Rajesh Mondal, Geetha Ramachandran, Shainaba A. Saadhali, Kannan Thiruvenkadam
Publikováno v:
Frontiers in Microbiology
Frontiers in Microbiology, Vol 11 (2020)
Frontiers in Microbiology, Vol 11 (2020)
The World Health Organization (WHO) has developed specific guidelines for critical concentrations (CCs) of antibiotics used for tuberculosis (TB) treatment, which is universally followed for drug susceptibility testing (DST) of clinical specimens. Ho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e020c3d1659b5ca2653cc4f13149b32c
http://europepmc.org/articles/PMC7338667
http://europepmc.org/articles/PMC7338667
Autor:
Rajadas Sam Ebenezer, Shanmuga Priya, Christy Rosaline Nirmal, Govindarajan Shanmugam, Magizhaveni Balasubramanian, Selvakumar Subbian, Kannan Thiruvenkadam, Rajesh Mondal, Angayarkanni Balasubramanian, Azger Dusthackeer, Geetha Ramachandran, A K Hemanth Kumar
Publikováno v:
Frontiers in Microbiology
Frontiers in Microbiology, Vol 10 (2019)
Frontiers in Microbiology, Vol 10 (2019)
Tuberculosis (TB) remains a leading killer among infectious diseases of humans worldwide. Delayed diagnosis is a crucial problem in global TB control programs. Bacteriological methods currently used to diagnose TB in endemic countries take up to 8 we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79422ca145a0f87c4fd6bbd31656241d
https://doi.org/10.3389/fmicb.2019.02381
https://doi.org/10.3389/fmicb.2019.02381